Singh Anmol, Dhruve Ritika, Singh Carol, Kumar Vikash, Sohal Aalam, Sejpal Divyesh
Department of Internal Medicine, Tristar Centennial Medical Center, Nashville, TN, USA (Anmol Singh).
Department of Medicine, University of Southwestern Texas, Dallas, TX, USA (Ritika Dhruve).
Ann Gastroenterol. 2025 May-Jun;38(3):328-336. doi: 10.20524/aog.2025.0957. Epub 2025 Apr 17.
Ileus is a well-known complication of acute pancreatitis (AP). There are limited data on the factors associated with ileus, as well as its impact on AP patients. We aimed to investigate the incidence and clinical predictors of ileus in hospitalized AP patients.
We queried the 2016-2019 National Inpatient Sample (NIS) database using the International Classification of Diseases (ICD)-10 codes. Adult patients diagnosed with AP (ICD-10 K85) were included, excluding those with chronic pancreatitis. Demographics, comorbidities, complications and interventions were stratified by the presence of ileus. Multivariate analysis identified factors associated with ileus, adjusting for patient and hospital characteristics, comorbidities, and pancreatitis complications.
Among 1,386,390 AP patients, 50,170 (3.6%) developed ileus. Female sex was associated with a lower risk (adjusted odds ratio [aOR] 0.56, 95% confidence interval [CI] 0.53-0.58; P<0.001). Hispanic patients had the lowest risk (aOR 0.82, 95%CI 0.76-0.88), while older age groups had a higher risk. Pseudocysts (P<0.001), sepsis (P<0.001) and portal vein thrombosis (P<0.001) were significant predictors. Pancreatic drainage was associated with ileus (P=0.007), but endoscopic retrograde cholangiopancreatography was not. Patients with ileus had greater mortality (P<0.001), longer hospital stays (+4.9 days, P<0.001), and higher costs ($67,855.91, P<0.001).
This study highlights age, sex and racial disparities in the development of ileus in patients with AP. It also reveals a significant association of ileus with pseudocysts, portal vein thrombosis, and pancreatic drainage. Early recognition and timely enteral feeding are crucial to prevent disease progression and improve outcomes.
肠梗阻是急性胰腺炎(AP)的一种常见并发症。关于与肠梗阻相关的因素及其对AP患者的影响的数据有限。我们旨在调查住院AP患者中肠梗阻的发生率和临床预测因素。
我们使用国际疾病分类(ICD)-10编码查询了2016 - 2019年全国住院患者样本(NIS)数据库。纳入诊断为AP(ICD-10 K85)的成年患者,排除患有慢性胰腺炎的患者。根据是否存在肠梗阻对人口统计学、合并症、并发症和干预措施进行分层。多变量分析确定了与肠梗阻相关的因素,并对患者和医院特征、合并症及胰腺炎并发症进行了校正。
在1386390例AP患者中,50170例(3.6%)发生了肠梗阻。女性发生肠梗阻的风险较低(调整后的优势比[aOR]为0.56,95%置信区间[CI]为0.53 - 0.58;P<0.001)。西班牙裔患者风险最低(aOR为0.82,95%CI为0.76 - 0.88),而年龄较大的患者风险较高。假性囊肿(P<0.001)、脓毒症(P<0.001)和门静脉血栓形成(P<0.001)是显著的预测因素。胰管引流与肠梗阻相关(P = 0.007),但内镜逆行胰胆管造影术与肠梗阻无关。发生肠梗阻的患者死亡率更高(P<0.001),住院时间更长(增加4.9天,P<0.001),费用更高(67855.91美元,P<0.001)。
本研究突出了AP患者发生肠梗阻时的年龄、性别和种族差异。它还揭示了肠梗阻与假性囊肿、门静脉血栓形成及胰管引流之间的显著关联。早期识别和及时肠内营养对于预防疾病进展和改善预后至关重要。